Pediatric Pneumonia Mycoplasma Positivity Trends in Ganzhou 2017-2024

Ganzhou, China data contains a retrospective analysis of 27,369 hospitalized pediatric community-acquired pneumonia patients from 2017 to 2024. The study by Guihua Lai investigates the impact of COVID-19 pandemic phases on Mycoplasma pneumoniae infection rates, seasonality, age distribution, and disease severity.

Use Cases

• Analyze MP positivity rate changes across pre-pandemic, NPI, and post-NPI phases using the 'Phase' and 'MP-positive' status fields.
• Model seasonal pattern shifts by examining 'season' and 'positivity rate' data, noting the significant increase in spring rates.
• Investigate age-specific susceptibility by analyzing 'age group' (1-3, 4-6, 7-10 years) and corresponding positivity rates across phases.
• Assess clinical severity outcomes by comparing 'proportion of severe pneumonia', 'hospitalization duration', and 'mechanical ventilation rate' across different time periods.
• Study the rebound effect of MP infections post-NPI relaxation using the Phase III positivity rate of 21.17% compared to earlier phases.

Strengths

• Analysis of 27,369 patient records provides a substantial sample size for epidemiological study.
• Covers a 7-year time range (2017-2024) spanning pre-pandemic, pandemic, and post-pandemic phases.
• Includes specific statistical results (e.g., χ² values, p-values) for key findings like positivity rate changes.

Limitations

• Dataset is very small at 38.5 KB, likely containing only summary statistics rather than patient-level records.
• Geographic scope is limited to a single city (Ganzhou), limiting generalizability.
• Data is presented in a DOC file format, which is not ideal for direct computational analysis.

Provenance

Source

figshare, authored by Guihua Lai.

Collection Method

Retrospective analysis of hospitalized pediatric CAP patient records.

Time Range

2017 to 2024.

Freshness

Data covers up to 2024 and was last updated in April 2026.

Geography

Ganzhou, China.